Navigation path

Left navigation

News

Europe’s drugs problem ‘increasingly complex’

27/05/2014

According to the European Drug Report 2014: Trends and developments released today by the EU drugs agency (EMCDDA) in Lisbon, is becoming increasingly complex with new challenges emerging. The agency describes an overall stable situation, with some positive signs in relation to the more established drugs. But this is counter-balanced by new threats posed by synthetic drugs, new psychoactive substances and medicinal products, all of which are becoming more prominent in a changing European drug market.

For more information:

Additional tools